Fig. 2.
Probability of acute and chronic graft-versus-host disease.
Probabilities of developing grade 2-4 acute GVHD (A) and extensive chronic GVHD (B) in 37 patients treated by escalating-dose or bulk-dose infusion regimens of donor lymphocytes in the 0.4 to 3.3 × 108/kg range.
